Comment on

• Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.

  Goldstein DS, Imrich R, Peckham E, Holmes C, Lopez G, Crews C, Hardy J, Singleton A, Hallett M. Goldstein DS, et al. Neurology. 2007 Oct 16;69(16):1580-4. doi: 10.1212/01.wnl.0000268696.57912.64. Epub 2007 Jul 11. Neurology. 2007. PMID: 17625107
• Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.

  Klein C, Schlossmacher MG. Klein C, et al. Neurology. 2007 Nov 27;69(22):2093-104. doi: 10.1212/01.wnl.0000271880.27321.a7. Epub 2007 Aug 29. Neurology. 2007. PMID: 17761553 Review.
• LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

  Nichols WC, Elsaesser VE, Pankratz N, Pauciulo MW, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T; Parkinson Study Group-PROGENI Investigators. Nichols WC, et al. Neurology. 2007 Oct 30;69(18):1737-44. doi: 10.1212/01.wnl.0000278115.50741.4e. Epub 2007 Sep 5. Neurology. 2007. PMID: 17804834
• Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

  Chen-Plotkin AS, Yuan W, Anderson C, McCarty Wood E, Hurtig HI, Clark CM, Miller BL, Lee VM, Trojanowski JQ, Grossman M, Van Deerlin VM. Chen-Plotkin AS, et al. Neurology. 2008 Feb 12;70(7):521-7. doi: 10.1212/01.WNL.0000280574.17166.26. Epub 2007 Oct 3. Neurology. 2008. PMID: 17914064 Free PMC article.